Pacira Pharmaceuticals CEO David Stack's 2021 pay falls 26% to $6.9M
Pacira Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Pacira Pharmaceuticals reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, five executives at Pacira Pharmaceuticals received on average a compensation package of $3M, a 24% decrease compared to previous year.
Average pay of disclosed executives at Pacira Pharmaceuticals
David Stack, Chief Executive Officer, received $6.9M in total, which decreased by 26% compared to 2020. 53% of Stack's compensation, or $3.7M, was in option awards. Stack also received $751K in bonus, $507K in non-equity incentive plan, $884K in salary, $1.1M in stock awards, as well as $15K in other compensation.
For fiscal year 2021, the median employee pay was $199,797 at Pacira Pharmaceuticals. Therefore, the ratio of David Stack's pay to the median employee pay was 35 to one.
Roy Winston, Chief Medical Officer, received a compensation package of $2.5M, which increased by 11% compared to previous year. 31% of the compensation package, or $761K, was in option awards.
Jonathan Slonin, Chief Clinical Officer, earned $2.1M in 2021.
Max Reinhardt, President, Rest of World, received $2M in 2021, which decreases by 15% compared to 2020.
Charles A. Reinhart, III, Chief Financial Officer, earned $1.7M in 2021, a 17% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2022.